Abiopharma

News list

Director Woods Eugene A. 🟢 acquired 186 shares (1 derivative) of JOHNSON & JOHNSON (JNJ) Transaction Date: Dec 09, 2025 | Filing ID: 000217

Full text

News bot Dec. 11, 2025, 10:06 p.m.
🔍 Woods Eugene A. (Director)

Company: JOHNSON & JOHNSON (JNJ)

Report Date: 2025-12-09
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 186
Detailed Transactions and Holdings:
- Acquired 186 shares of Deferred Share Units (Derivative)
  Date: 2025-12-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,058.07 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
Footnotes:
- F1: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
- F2: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.